InvestorsObserver is giving FibroGen Inc (FGEN) an Analyst Rating Rank of 4, meaning FGEN is ranked higher by analysts than 4% of stocks. The average price target for FGEN is $14.5 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating FGEN a Hold today. Find out what this means to you and get the rest of the rankings on FGEN!